Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 4 Planned sale Chief Scientific Officer sold 8,000 shares at $17.82 ($142,560)
  2. 144 Insider Sale of Securities
  3. 4 Grant or award Chief Legal Officer acquired 2,470 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 1,541 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 8-K Event Shareholder vote results
  12. 8-K Event Regulation FD disclosure · Other events
  13. 8-K Event Regulation FD disclosure · Other events
  14. 8-K Event Regulation FD disclosure · Other events
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Planned sale Chief Scientific Officer sold 8,000 shares at an average $14.62 ($116,996)
  19. 144 Insider Sale of Securities
  20. S-3ASR Offering Registration Statement

Page 2 of 24 · 471 filings